GPNZ Comms Circular 25 August 2020

24 Aug 2020

Auckland University Survey  - the consequences on practices, staff and patients of the COVID-19 pandemic.

Thanks to everyone who completed the 4th survey on COVID-19 pandemic and its aftermath. Results are here

The survey has moved back to fortnightly, given the current cluster outbreak. Please consider taking and promoting the 5th survey click here. It only takes about 3 minutes to complete. Survey closes 27 August.

 

ACC Weekly Claims Data – 15 August

We’re providing some high-level claims information to help with your business planning during the COVID-19 response. For last week (the week ending Saturday 15 August):
  

 

w/e 15 August

% change from previous week

Average last four weeks

% change from corresponding four weeks last year

New claims accepted

39,295

-9%

41,493

12%

Clients starting to receive Weekly Compensation

1,640

-13%

1,709

3%

Rehabilitation services costs paid (net)

$13.8M

7%

$12.6M

0%

Rehabilitation costs include services such as social and vocational rehabilitation but exclude treatment services such as general practitioner and physiotherapy services. It’s possible that future reporting for the same time period may differ slightly due to processing lags. 

 

MSD and Medical Certificates

Attached is the “official” word from MSD on Medical Certificates as required now under the temporary changes related to Covid-19.  The key message is the decision to defer a requirement for subsequent Work Capacity Medical Certificates through until after July 31st 2021. New applications should still be given a Medical Certificate to best establish which Benefit they should receive.  Given the significant negative health and financial consequences of being out of work for an extended time MSD would urge all providers to encourage your patients to consider suitable work as soon as it is appropriate. Despite the current pressure on employers there are jobs out there.  

 

HQSC

The Health Quality & Safety Commission will promote Te Rā Haumaru Tūroro o Aotearoa | Aotearoa Patient Safety Day on 17 November 2020. The theme is Getting through together | Whāia e tātou te pae tawhiti.

Activities for Aotearoa Patient Safety Day include (but are not limited to):

  • short videos from health care workers, consumers and whānau about the impact of crisis events and how they dealt with them
  • a webinar focusing on mental health and wellbeing, to be held on 17 November. Information about the webinar and how to register will be sent out to our Aotearoa Patient Safety Day contacts, and promoted on the Commission website, in our e-Digest and on our social media channels
  • links to existing mental health and wellbeing resources
  • a social media toolkit.

For more information about Aotearoa Patient Safety Day, contact communications@hqsc.govt.nz.

 

Health Quality & Safety Commission 2020 report- Te Mauri The Life Force | Rangatahi suicide report | Te pūrongo mō te mate whakamomori o te rangatahi. Is now available: https://www.hqsc.govt.nz/our-programmes/mrc/sumrc/publications-and-resources/publication/3949

 

PHARMAC:

Mylan, the supplier of celiprolol tab 200 mg (brand name Celol) has informed PHARMAC it is discontinuing supply of this product because it can no longer source the active pharmaceutical ingredient.  Celiprolol is a beta-blocker used by approximately 4,000 people (use of this medicine has been declining over recent years). We are aware that pharmacies are currently having difficulty sourcing celiprolol from wholesalers and it seems like that stock of this has depleted much earlier than was originally anticipated.  We recommend that people taking celiprolol go back to their prescriber to discuss changing to an alternative funded beta-blocker.  PHARMAC's external clinical advisors have advised there are a number of suitable funded beta-blockers available that prescribers may wish to change their patients to.  Prescribers can access advice on alternative beta-blockers from BPACnz: https://bpac.org.nz/2017/beta-blockers.aspx

We know that it is not always easy to change patients onto different medicines and apologise for any inconvenience caused by this discontinuation.

 

If you consider any patient cannot change treatments or is experiencing exceptional clinical impacts as a transition to another beta-blocker, you may want to consider submitting a NPPA funding application to PHARMAC. Please note that the Celol brand of celiprolol will no longer be available and the approval of NPPA funding does not guarantee or secure supply of an alternative product. Please check our website for up to date information about supply issues.  Please email enquiry@pharmac.govt.nz if you have any questions.

 

Interesting Links:

Team self-care and support during the challenging long-game (thanks Laila): https://www.resorgs.org.nz/recovery-sprint-marathon-or-adventure-race/

Ian Powell’s piece on the CDHB Management Challenge: https://democracyproject.nz/2020/08/16/ian-powell-centralised-authoritarian-culture-behind-canterbury-health-crisis/?fbclid=IwAR08aaBcjAQmIBJTCOiWKiaSjy2nLSSn3Tdz6QQpOidru4MI6TM0x1IPtqE

 

Ngā mihi,